Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,049.95
-5.9724-0.29%
Number of Gainers:472
Number of Losers:529
Number of Flat:23
PE:- -
High:2,056.94
Open:2,055.94
Low:2,041.62
Close:2,055.92
Volume:5.51B
Turnover:716.16B
Market Cap:95.54T
Float Cap:89.34T

Loading ...

Enbridge Completes Major Equity Offering to Bolster Capital

TIPRANKS
·
Yesterday

Nasus Pharma Wins FDA Clearance to Begin NS002 Anaphylaxis Trial

TIPRANKS
·
Yesterday

BioNTech and OncoC4 Report Survival Gains for Gotistobart in Phase 3 Squamous NSCLC Trial

TIPRANKS
·
Yesterday

Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson

Reuters
·
Yesterday

Dogwood Therapeutics Completes Enrollment in Halneuron Phase 2b Chemotherapy-Induced Neuropathic Pain Trial

Reuters
·
Yesterday

Liberty Star Minerals Names Former US Energy Secretary Rick Perry Critical Minerals Adviser to Board

Reuters
·
Yesterday

Largest borrow rate increases among liquid names

TIPRANKS
·
Yesterday

Meta Platforms is Maintained at Neutral by Wedbush

Dow Jones
·
Yesterday

BASF Mandates Investment Banks for Planned IPO of Agricultural Solutions

Reuters
·
Yesterday

Pre-Market: Nasdaq Futures Drop 1.39% as AI Leaders Urge Slower Development

Deep News
·
Yesterday

Weichai Power Sets Timetable and Terms for 2026 Interim Dividend on H Shares

TIPRANKS
·
Yesterday

Weichai Power updates details of 2026 interim cash dividend

TIPRANKS
·
Yesterday

Jack Henry initiated with an Overweight at KeyBanc

TIPRANKS
·
Yesterday

AJ Bell executives boost holdings with BAYE share purchases

TIPRANKS
·
Yesterday

Mortgage rates at five-month high ahead of Bank of England decision

cityam
·
Yesterday

Baird cuts Canada Goose target, adds ‘Bearish Fresh Pick’

TIPRANKS
·
Yesterday

Franco-Nevada Boosts Bullabulling Gold Exposure with A$200 Million Follow-On Financing

TIPRANKS
·
Yesterday

Baird places ‘Bearish Fresh Pick’ on Under Armour

TIPRANKS
·
Yesterday

Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline

TIPRANKS
·
Yesterday